rs3219170
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020919.4(ALS2):c.4581-48T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.922 in 1,485,640 control chromosomes in the GnomAD database, including 631,949 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.89 ( 61068 hom., cov: 32)
Exomes 𝑓: 0.92 ( 570881 hom. )
Consequence
ALS2
NM_020919.4 intron
NM_020919.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.198
Publications
9 publications found
Genes affected
ALS2 (HGNC:443): (alsin Rho guanine nucleotide exchange factor ALS2) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
ALS2 Gene-Disease associations (from GenCC):
- ALS2-related motor neuron diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- amyotrophic lateral sclerosis type 2, juvenileInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- infantile-onset ascending hereditary spastic paralysisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- juvenile primary lateral sclerosisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-201705509-A-G is Benign according to our data. Variant chr2-201705509-A-G is described in ClinVar as Benign. ClinVar VariationId is 261379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.962 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.894 AC: 136002AN: 152088Hom.: 61021 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
136002
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.923 AC: 221992AN: 240488 AF XY: 0.928 show subpopulations
GnomAD2 exomes
AF:
AC:
221992
AN:
240488
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.925 AC: 1233347AN: 1333434Hom.: 570881 Cov.: 19 AF XY: 0.927 AC XY: 621142AN XY: 670362 show subpopulations
GnomAD4 exome
AF:
AC:
1233347
AN:
1333434
Hom.:
Cov.:
19
AF XY:
AC XY:
621142
AN XY:
670362
show subpopulations
African (AFR)
AF:
AC:
25139
AN:
30478
American (AMR)
AF:
AC:
39194
AN:
44058
Ashkenazi Jewish (ASJ)
AF:
AC:
23084
AN:
25258
East Asian (EAS)
AF:
AC:
38384
AN:
38744
South Asian (SAS)
AF:
AC:
79229
AN:
82654
European-Finnish (FIN)
AF:
AC:
50627
AN:
53080
Middle Eastern (MID)
AF:
AC:
4352
AN:
4816
European-Non Finnish (NFE)
AF:
AC:
921869
AN:
998496
Other (OTH)
AF:
AC:
51469
AN:
55850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4692
9383
14075
18766
23458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18568
37136
55704
74272
92840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.894 AC: 136108AN: 152206Hom.: 61068 Cov.: 32 AF XY: 0.898 AC XY: 66792AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
136108
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
66792
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
33995
AN:
41514
American (AMR)
AF:
AC:
13486
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
3171
AN:
3470
East Asian (EAS)
AF:
AC:
5106
AN:
5186
South Asian (SAS)
AF:
AC:
4621
AN:
4818
European-Finnish (FIN)
AF:
AC:
10196
AN:
10612
Middle Eastern (MID)
AF:
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
AC:
62524
AN:
68006
Other (OTH)
AF:
AC:
1856
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
723
1446
2170
2893
3616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3327
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Infantile-onset ascending hereditary spastic paralysis Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Juvenile primary lateral sclerosis Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Amyotrophic lateral sclerosis type 2, juvenile Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.